You just read:

First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial

News provided by

BiondVax Pharmaceuticals Ltd.

Jul 08, 2019, 05:46 ET